Microencapsulated Chitosan-Based Nanocapsules: A New Platform for Pulmonary Gene Delivery

In this work, we propose chitosan (CS)-based nanocapsules (NCs) for pulmonary gene delivery. Hyaluronic acid (HA) was incorporated in the NCs composition (HA/CS NCs) aiming to promote gene transfection in the lung epithelium. NCs were loaded with a model plasmid (pCMV-βGal) to easily evaluate their...

Full description

Bibliographic Details
Main Authors: Estefanía Fernández-Paz, Lucía Feijoo-Siota, Maria Manuela Gaspar, Noemi Csaba, Carmen Remuñán-López
Format: Article
Language:English
Published: MDPI AG 2021-08-01
Series:Pharmaceutics
Subjects:
Online Access:https://www.mdpi.com/1999-4923/13/9/1377
_version_ 1797517635114500096
author Estefanía Fernández-Paz
Lucía Feijoo-Siota
Maria Manuela Gaspar
Noemi Csaba
Carmen Remuñán-López
author_facet Estefanía Fernández-Paz
Lucía Feijoo-Siota
Maria Manuela Gaspar
Noemi Csaba
Carmen Remuñán-López
author_sort Estefanía Fernández-Paz
collection DOAJ
description In this work, we propose chitosan (CS)-based nanocapsules (NCs) for pulmonary gene delivery. Hyaluronic acid (HA) was incorporated in the NCs composition (HA/CS NCs) aiming to promote gene transfection in the lung epithelium. NCs were loaded with a model plasmid (pCMV-βGal) to easily evaluate their transfection capacity. The plasmid encapsulation efficiencies were of approx. 90%. To facilitate their administration to the lungs, the plasmid-loaded NCs were microencapsulated in mannitol (Ma) microspheres (MS) using a simple spray-drying technique, obtaining dry powders of adequate properties. In vivo, the MS reached the deep lung, where the plasmid-loaded CS-based NCs were released and transfected the alveolar cells more homogeneously than the control formulation of plasmid directly microencapsulated in Ma MS. The HA-containing formulation achieved the highest transfection efficiency, in a more extended area and more homogeneously distributed than the rest of tested formulations. The new micro-nanostructured platform proposed in this work represents an efficient strategy for the delivery of genetic material to the lung, with great potential for the treatment of genetic lung diseases.
first_indexed 2024-03-10T07:18:18Z
format Article
id doaj.art-63997b4b1b9646ff9809c2e257dcbe8d
institution Directory Open Access Journal
issn 1999-4923
language English
last_indexed 2024-03-10T07:18:18Z
publishDate 2021-08-01
publisher MDPI AG
record_format Article
series Pharmaceutics
spelling doaj.art-63997b4b1b9646ff9809c2e257dcbe8d2023-11-22T14:46:44ZengMDPI AGPharmaceutics1999-49232021-08-01139137710.3390/pharmaceutics13091377Microencapsulated Chitosan-Based Nanocapsules: A New Platform for Pulmonary Gene DeliveryEstefanía Fernández-Paz0Lucía Feijoo-Siota1Maria Manuela Gaspar2Noemi Csaba3Carmen Remuñán-López4Nanobiofar Group, Department of Pharmacology, Pharmacy & Pharmaceutical Technology, Faculty of Pharmacy, University of Santiago de Compostela, 15782 Santiago de Compostela, SpainDepartment of Microbiology & Parasitology, Faculty of Pharmacy, University of Santiago de Compostela, 15782 Santiago de Compostela, SpainResearch Institute for Medicines (iMed.ULisboa), Faculty of Pharmacy, University of Lisboa, Av. Professor GamaPinto, 1649-003 Lisbon, PortugalNanobiofar Group, Center of Research in Molecular Medicine and Chronic Diseases (CiMUS), University of Santiago de Compostela, Campus Vida, 15706 Santiago de Compostela, SpainNanobiofar Group, Department of Pharmacology, Pharmacy & Pharmaceutical Technology, Faculty of Pharmacy, University of Santiago de Compostela, 15782 Santiago de Compostela, SpainIn this work, we propose chitosan (CS)-based nanocapsules (NCs) for pulmonary gene delivery. Hyaluronic acid (HA) was incorporated in the NCs composition (HA/CS NCs) aiming to promote gene transfection in the lung epithelium. NCs were loaded with a model plasmid (pCMV-βGal) to easily evaluate their transfection capacity. The plasmid encapsulation efficiencies were of approx. 90%. To facilitate their administration to the lungs, the plasmid-loaded NCs were microencapsulated in mannitol (Ma) microspheres (MS) using a simple spray-drying technique, obtaining dry powders of adequate properties. In vivo, the MS reached the deep lung, where the plasmid-loaded CS-based NCs were released and transfected the alveolar cells more homogeneously than the control formulation of plasmid directly microencapsulated in Ma MS. The HA-containing formulation achieved the highest transfection efficiency, in a more extended area and more homogeneously distributed than the rest of tested formulations. The new micro-nanostructured platform proposed in this work represents an efficient strategy for the delivery of genetic material to the lung, with great potential for the treatment of genetic lung diseases.https://www.mdpi.com/1999-4923/13/9/1377chitosan nanocapsulesin vivo studymicrospherespCMV-βGalpulmonary gene deliveryspray-drying
spellingShingle Estefanía Fernández-Paz
Lucía Feijoo-Siota
Maria Manuela Gaspar
Noemi Csaba
Carmen Remuñán-López
Microencapsulated Chitosan-Based Nanocapsules: A New Platform for Pulmonary Gene Delivery
Pharmaceutics
chitosan nanocapsules
in vivo study
microspheres
pCMV-βGal
pulmonary gene delivery
spray-drying
title Microencapsulated Chitosan-Based Nanocapsules: A New Platform for Pulmonary Gene Delivery
title_full Microencapsulated Chitosan-Based Nanocapsules: A New Platform for Pulmonary Gene Delivery
title_fullStr Microencapsulated Chitosan-Based Nanocapsules: A New Platform for Pulmonary Gene Delivery
title_full_unstemmed Microencapsulated Chitosan-Based Nanocapsules: A New Platform for Pulmonary Gene Delivery
title_short Microencapsulated Chitosan-Based Nanocapsules: A New Platform for Pulmonary Gene Delivery
title_sort microencapsulated chitosan based nanocapsules a new platform for pulmonary gene delivery
topic chitosan nanocapsules
in vivo study
microspheres
pCMV-βGal
pulmonary gene delivery
spray-drying
url https://www.mdpi.com/1999-4923/13/9/1377
work_keys_str_mv AT estefaniafernandezpaz microencapsulatedchitosanbasednanocapsulesanewplatformforpulmonarygenedelivery
AT luciafeijoosiota microencapsulatedchitosanbasednanocapsulesanewplatformforpulmonarygenedelivery
AT mariamanuelagaspar microencapsulatedchitosanbasednanocapsulesanewplatformforpulmonarygenedelivery
AT noemicsaba microencapsulatedchitosanbasednanocapsulesanewplatformforpulmonarygenedelivery
AT carmenremunanlopez microencapsulatedchitosanbasednanocapsulesanewplatformforpulmonarygenedelivery